NCT06106152 2024-03-26
WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase EARLY_PHASE1 Unknown
Second Affiliated Hospital, School of Medicine, Zhejiang University
Mabwell (Shanghai) Bioscience Co., Ltd.
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd